fluvoxamine

Last year, researchers who were testing cheap generic drugs in the hope that one or more of them might prove to work as a Covid-19 treatment stumbled across a promising candidate: the antidepressant fluvoxamine. In a massive randomized controlled trial, called Together, researchers at McMaster University compared eight different repurposed drugs, and found most of them — including ivermectin, the antiparasitic that many embraced as a Covid-19 miracle cure — failed to do much against the disease. But fluvoxamine…

When the US Food and Drug Administration rejected an antidepressant as a treatment for COVID-19 on Monday, it also released a 27-page memorandum explaining exactly why it wasn’t convinced the drug was effective. It’s an unusual move for the agency, which typically rejects drugs quietly without quite so much publicly available paperwork. The antidepressant fluvoxamine is a cheap, generic drug that’s been used for decades. Research shows that the drug can also block inflammation in the body. So, some researchers hoped…